Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

270 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Diet and colorectal cancer: still an open question.
Schatzkin A, Freedman LS, Lanza E, Tangrea J. Schatzkin A, et al. Among authors: freedman ls. J Natl Cancer Inst. 1995 Dec 6;87(23):1733-5. doi: 10.1093/jnci/87.23.1733. J Natl Cancer Inst. 1995. PMID: 7473825 No abstract available.
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.
Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK. Albanes D, et al. Among authors: freedman ls. J Natl Cancer Inst. 1996 Nov 6;88(21):1560-70. doi: 10.1093/jnci/88.21.1560. J Natl Cancer Inst. 1996. PMID: 8901854 Clinical Trial.
What does it mean to be a cancer gene carrier? Problems in establishing causality from the molecular genetics of cancer.
Schatzkin A, Goldstein A, Freedman LS. Schatzkin A, et al. Among authors: freedman ls. J Natl Cancer Inst. 1995 Aug 2;87(15):1126-30. doi: 10.1093/jnci/87.15.1126. J Natl Cancer Inst. 1995. PMID: 7674316 Review.
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer.
Schatzkin A, Freedman LS, Dawsey SM, Lanza E. Schatzkin A, et al. Among authors: freedman ls. J Natl Cancer Inst. 1994 Jul 20;86(14):1053-7. doi: 10.1093/jnci/86.14.1053. J Natl Cancer Inst. 1994. PMID: 7802771 Review. No abstract available.
Validation of intermediate end points in cancer research.
Schatzkin A, Freedman LS, Schiffman MH, Dawsey SM. Schatzkin A, et al. Among authors: freedman ls. J Natl Cancer Inst. 1990 Nov 21;82(22):1746-52. doi: 10.1093/jnci/82.22.1746. J Natl Cancer Inst. 1990. PMID: 2231769
Re: Risk/benefit assessment of tamoxifen to prevent breast cancer-still a work in progress?
Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V. Gail MH, et al. Among authors: freedman l. J Natl Cancer Inst. 2000 Apr 5;92(7):574-5. doi: 10.1093/jnci/92.7.574. J Natl Cancer Inst. 2000. PMID: 10749915 No abstract available.
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V. Gail MH, et al. Among authors: freedman l. J Natl Cancer Inst. 1999 Nov 3;91(21):1829-46. doi: 10.1093/jnci/91.21.1829. J Natl Cancer Inst. 1999. PMID: 10547390 Review.
Nutrition and physical activity and chronic disease prevention: research strategies and recommendations.
Prentice RL, Willett WC, Greenwald P, Alberts D, Bernstein L, Boyd NF, Byers T, Clinton SK, Fraser G, Freedman L, Hunter D, Kipnis V, Kolonel LN, Kristal BS, Kristal A, Lampe JW, McTiernan A, Milner J, Patterson RE, Potter JD, Riboli E, Schatzkin A, Yates A, Yetley E. Prentice RL, et al. Among authors: freedman l. J Natl Cancer Inst. 2004 Sep 1;96(17):1276-87. doi: 10.1093/jnci/djh240. J Natl Cancer Inst. 2004. PMID: 15339966 Review.
270 results
Jump to page
Feedback